Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?

GLOBOCAN 2020 estimated more than 19.3 million new cases, and about 10 million patients were deceased from cancer in 2020. Clinical manifestations showed that several growth factor receptors consisting of transmembrane and cytoplasmic tyrosine kinase (TK) domains play a vital role in cancer progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongre, Raj Kumar, Mishra, Chandra Bhushan, Shukla, Arvind Kumar, Prakash, Amresh, Jung, Samil, Ashraf-Uz-Zaman, Md, Lee, Myeong-Sok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584061/
https://www.ncbi.nlm.nih.gov/pubmed/34769090
http://dx.doi.org/10.3390/ijms222111659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584061/
https://www.ncbi.nlm.nih.gov/pubmed/34769090
http://dx.doi.org/10.3390/ijms222111659

Ejemplares similares